Yifan Zheng
Overview
Explore the profile of Yifan Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
753
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li L, Guo D, Shi C, Zheng Y
J Affect Disord
. 2025 Feb;
378:81-89.
PMID: 40015649
Objective: This study aims to investigate the predictive value of sedentary behavior and physical activity in adolescent depressive symptoms. Methods: A total of 2419 adolescent students (grades 7-12) from six...
2.
Tian K, Zheng Y, Sun Z, Yin Z, Zhu K, Liu C
Sensors (Basel)
. 2025 Feb;
25(4).
PMID: 40006396
As cities increasingly prioritize green and low-carbon transportation, the development of effective cycling infrastructure has become essential for alleviating traffic congestion and reducing environmental impacts. However, the service quality of...
3.
Duan Q, Yuan M, Ma X, Zheng Y, Meng R, Shi W, et al.
Eur J Med Chem
. 2025 Feb;
289:117387.
PMID: 39999691
The prevalence of MDR Gram-negative bacteria has posed a great impetus for the discovery of new therapeutic approaches. Here, we synthesized a series of pyrylium derivatives as antibiotic adjuvants based...
4.
Cao R, Zhang Z, Shi R, Lu J, Zheng Y, Sun Y, et al.
Nat Commun
. 2025 Feb;
16(1):1651.
PMID: 39952987
For the intricate and infrequent safety issues of batteries, online safety fault diagnosis over stochastic working conditions is indispensable. In this work, we employ deep learning methods to develop an...
5.
Zheng Y, Gong J, Lester C
J Am Pharm Assoc (2003)
. 2025 Feb;
:102349.
PMID: 39938651
Background: The RxChange process provides a streamlined solution within electronic prescribing workflows for a pharmacist-led team to address prescription issues with providers. Its use and effectiveness need to be evaluated...
6.
Kim J, Marshall V, Rowell B, Chen Q, Zheng Y, Lee J, et al.
JMIR Hum Factors
. 2025 Feb;
12:e60273.
PMID: 39932773
Background: Dispensing errors significantly contribute to adverse drug events, resulting in substantial health care costs and patient harm. Automated pill verification technologies have been developed to aid pharmacists with medication...
7.
Ye C, Chen L, Zhang L, Zheng Y, Liu X, Huang Z, et al.
Cytokine
. 2025 Feb;
188:156874.
PMID: 39904110
Objective: To comprehensively investigate the impact of candidate loci on the susceptibility to neuropsychiatric systemic lupus erythematosus (NPSLE) in a cohort of Chinese children with lupus nephritis (LN). Methods: This...
8.
Ge Y, Yin J, Chen C, Yang S, Han Y, Ding C, et al.
Front Aging Neurosci
. 2025 Jan;
16():1470836.
PMID: 39834619
Background: As a clinical precursor to Alzheimer's disease (AD), amnestic mild cognitive impairment (aMCI) bears a considerably heightened risk of transitioning to AD compared to cognitively normal elders. Early prediction...
9.
Yang Y, Zheng Y, Tong T, Dong J, Zhao M, Zhang G, et al.
Adv Mater
. 2025 Jan;
37(8):e2414201.
PMID: 39828516
Currently, there is no conclusive evidence indicating that in situ self-assembled Gd nanostructures of varying sizes demonstrate distinct T and T signal enhancement capabilities. Furthermore, it remains uncertain whether size...
10.
Zhang X, Ma L, Cai K, Guo X, Zhang G, Dong J, et al.
Bioconjug Chem
. 2025 Jan;
36(1):20-24.
PMID: 39810600
Positron-emission tomography (PET) offers high sensitivity for cancer diagnosis. However, small-molecule-based probes often exhibit insufficient accumulation in tumor sites, while nanoparticle-based agents typically have limited delivery efficiency. To address this...